Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

CBD Market 'Surges' As FDA Delays Setting Regulatory Policy – NPA

Mar 22 2019

• By Eileen Francis

Cannibis

Related Content

It's Complicated: FDA Prohibits CBD In Supplements, Enforcement Priority On Disease Claims

Jun 25 2018

Lauder/Origins' Hello, Calm Mask: Gateway To Bigger Cannabis Skin-Care Play?

Sep 18 2018

Farm Bill Hemp Provision Lights Another Supplement Industry Regulatory Priority

Jan 25 2019

With High Profile At FDA, Gottlieb Headed Ambitious Consumer Health Initiatives

Mar 06 2019

House Appropriators Stoke Flames For FDA Regulation On CBD In Supplements

Mar 01 2019

Additional Topics

United States US States Dietary Supplements Regulation FDA Advertising, Marketing & Sales Commercial Companies Compliance Policy Consumer

More from Regulation

More from Policy & Regulation

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window